OL
ABBV icon

Optas LLC’s AbbVie ABBV Stock Holding History

Optas LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
7,513
-56
-0.7% -$12K 0.26% 54
2026
Q1 		$1.65M Buy
7,569
+576
+8% +$128K 0.25% 51
2025
Q4 		$1.6M Buy
6,993
+373
+6% +$85K 0.25% 49
2025
Q3 		$1.53M Buy
6,620
+393
+6% +$80K 0.26% 51
2025
Q2 		$1.16M Buy
6,227
+1,142
+22% +$212K 0.22% 58
2025
Q1 		$1.07M Buy
5,085
+261
+5% +$50.7K 0.19% 58
2024
Q4 		$857K Buy
4,824
+309
+7% +$56.8K 0.18% 68
2024
Q3 		$892K Buy
4,515
+610
+16% +$114K 0.21% 71
2024
Q2 		$670K Buy
3,905
+323
+9% +$53.5K 0.17% 71
2024
Q1 		$652K Buy
3,582
+355
+11% +$61.2K 0.18% 75
2023
Q4 		$500K Sell
3,227
-1,669
-34% -$243K 0.15% 87
2023
Q3 		$730K Buy
4,896
+563
+13% +$82.7K 0.24% 65
2023
Q2 		$584K Sell
4,333
-445
-9% -$65.3K 0.2% 83
2023
Q1 		$761K Buy
4,778
+247
+5% +$37.8K 0.27% 62
2022
Q4 		$732K Buy
4,531
+41
+0.9% +$6.29K 0.3% 54
2022
Q3 		$603K Buy
4,490
+168
+4% +$24.1K 0.26% 62
2022
Q2 		$661K Buy
4,322
+1,562
+57% +$239K 0.27% 57
2022
Q1 		$447K Buy
2,760
+81
+3% +$11.8K 0.15% 90
2021
Q4 		$363K Buy
2,679
+107
+4% +$12.6K 0.1% 111
2021
Q3 		$278K Sell
2,572
-43
-2% -$4.91K 0.08% 118
2021
Q2 		$294K Buy
2,615
+43
+2% +$4.84K 0.08% 115
2021
Q1 		$279K Hold
2,572
– – 0.09% 114
2020
Q4 		$276K Sell
2,572
-2,370
-48% -$228K 0.09% 108
2020
Q3 		$431K Buy
4,942
+2,830
+134% +$266K 0.13% 103
2020
Q2 		$208K Buy
+2,112
New +$186K 0.08% 118

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Optas LLC's ABBV Position: Q2 2026 in Review

Optas LLC reduced its AbbVie (ABBV) stake by 0.74% in Q2 2026, selling an estimated $12K and leaving 7,513 shares worth $1.89M. The position accounts for 0.26% of the portfolio, ranked #54.

Optas LLC first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Optas LLC held 7,513 shares of AbbVie worth $1.89M as of Q2 2026.
  • Optas LLC sold 56 AbbVie shares in Q2 2026, an estimated $12K.
  • AbbVie made up 0.26% of Optas LLC's portfolio in Q2 2026, its #54 holding.
  • Optas LLC first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.